Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2010 - 2026)

Jazz Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $149.7 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 42.38% year-over-year to $149.7 million in Q1 2026; TTM through Mar 2026 was $149.7 million, a 42.38% decrease from a year earlier, with the FY2025 full-year figure at $152.5 million, down 14.04% from the prior year.
• Prepaid Assets fell to $149.7 million in Q1 2026 per JAZZ's latest filing, from $152.5 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $320.8 million in Q4 2023 and bottomed at $72.8 million in Q1 2023.
• The 5-year median for Prepaid Assets is $152.5 million (2025), against an average of $183.4 million.
• Across the five-year window, Prepaid Assets jumped 164.64% in 2022 and slumped 56.01% in 2023, its largest moves.
• Year by year, Prepaid Assets stood at $267.2 million in 2022, then increased by 20.07% to $320.8 million in 2023, then slumped by 44.7% to $177.4 million in 2024, then dropped by 14.04% to $152.5 million in 2025, then decreased by 1.84% to $149.7 million in 2026.
• Per Business Quant, the three latest JAZZ Prepaid Assets figures stand at $149.7 million (Q1 2026), $152.5 million (Q4 2025), and $315.4 million (Q3 2025).